Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample

American Journal of Gastroenterology

Volumn 103, Issue 7, 2008, Pages 1674-1681

  Bajaj, Jasmohan S ^a,b   Ananthakrishnan, Ashwin N ^b   McGinley, Emily L ^d   Hoffmann, Raymond G ^c   Brasel, Karen J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Division of Gastroenterology and Hepatology   (United States)

^c Division of Biostatistics   (United States)

^d Epidemiology Data Service Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR VEHICLE; PREVALENCE; PRIORITY JOURNAL; AGE; ECONOMICS; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; INJURY; MIDDLE AGED; TRAFFIC ACCIDENT; UNITED STATES;

ACCIDENTS, TRAFFIC; ADULT; AGE FACTORS; AGED; COMORBIDITY; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; UNITED STATES; WOUNDS AND INJURIES;

EID: 50649115529     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01814.x     Document Type: Article

References (46)

1. Evans L. The dominant role of driver behavior in traffic safety. Am J Public Health 1996;86:784-6.
2. U.S. Department of Transportation. National Highway Traffic Safety Administration. Race and ethnicity infatal motor vehicle traffic crashes 1999-2004. Available at: http://www- nrd.nhtsa.dot.gov/Pubs/809956.pdf. Accessed September 15, 2007.
3. Roberts SE, Goldacre MJ, Yeates D. Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999. Gut 2005;54:1615-21.
4. Caputo F, Trevisani F, Bernardi M. Alcohol misuse and traffic accidents. Lancet 2007;369:463-4.
5. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy- definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hep- atology 2002;35:716-21.
6. Blei AT, Cordoba J. Hepatic encephalopathy. Am J Gas- troenterol 2001;96:1968-76.
7. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopa- thy: Diagnosis, clinical significance and recommendations. J Hepatol 2005;42(Suppl 1):S45-53.
8. Qadri AM, Ogunwale BO, Mullen KD. Can we ignore minimal hepatic encephalopathy any longer? Hepatology 2007;45:547-8.
9. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, et al. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96:2718-23.
10. Weissenborn K. Minimal hepatic encephalopathy: Aperma- nent source of discussion. Hepatology 2002;35:494-6.
11. Wein C, Koch H, Popp B, et al. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004;39:739-45.
12. Munoz SJ. Driving with minimal hepatic encephalopa- thy: Real world consequences? Am J Gastroenterol 2007;102:1910-1.
13. BajajJS, HafeezullahM, HoffmannRG, etal. Minimal hepatic encephalopathy: A vehicle for accidents and traffic violations. Am J Gastroenterol 2007;102:1903-9.
14. Christmas AB, Wilson AK, Franklin GA, et al. Cirrhosis and trauma: A deadly duo. Am Surg 2005;71:996-1000.
15. Demetriades D, Constantinou C, Salim A, et al. Liver cirrhosis in patients undergoing laparotomy for trauma: Effect on outcomes. J Am Coll Surg 2004;199:538-42.
16. Dangleben DA, Jazaeri O, Wasser T, et al. Impact of cirrhosis on outcomes in trauma. J Am Coll Surg 2006;203:908-13.
17. Wahlstrom K, Ney AL, Jacobson S, et al. Trauma in cir- rhotics: Survival and hospital sequelae in patients requiring abdominal exploration. Am Surg 2000;66:1071-6.
18. Nguyen GC, Segev DL, Thuluvath PJ. Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: A national study. Hepatology 2007;45:1282-9.
19. Agency for Healthcare Research and Quality. HCUP Nationwide Inpatient Sample (NIS), 2004. Available at: http://www.hcup-us.ahrq.gov/db/nation/nis/NIS- Introduction-2004.pdf. Accessed September 10, 2007.
20. Whalen D, Houchens R, Elixhauser A. 2002 HCUP Nationwide Inpatient Sample (NIS) comparison report. Rockville, MD: U.S. Agency for Healthcare Research and Quality, 2005.
21. Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-9.
22. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical co- morbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
23. MacKenzie EJ, Steinwachs DM, Shankar B. Classifying trauma severity based on hospital discharge diagnoses. Validation of an ICD-9CM to AIS-85 conversion table. Med Care 1989;27:412-22.
24. Baker SP, O'Neill B, Haddon W Jr, et al. The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974;14:187-96.
25. Mackenzie ES, Newman AC, Sacco WJ, et al. ICDMAP-90 Software user's guide. Baltimore, MD: The Johns Hopkins Center for Injury Research and Policy and Tri-Analysis Inc., 1997.
26. Bajaj JS, Saeian K, Verber MD, et al. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 2007;102:754- 60.
27. Watanabe A, Sakai T, Sato S, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997;26:1410-4.
28. Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopa- thy. Hepatology 2007;45:549-59.
29. Morris JA Jr, MacKenzie EJ, Edelstein SL. The effect of preexisting conditions on mortality in trauma patients. JAMA 1990;263:1942-6.
30. Greenspan AI, Coronado VG, Mackenzie EJ, et al. Injury hospitalizations: Using the Nationwide Inpatient Sample. J Trauma 2006;61:1234-43.
31. Hannan EL, Farrell LS. Predicting trauma inpatient mortality in an administrative database: An investigation of survival risk ratios using New York data. J Trauma 2007;62:964-8.
32. Mullins RJ, Diggs BS, Hedges JR, etal. Regionaldifferences in outcomes for hospitalized injured patients. J Trauma 2006;60:691-8; discussion 699-700.
33. Coben JH, Steiner CA, Owens P. Motorcycle-related hos- pitalizations in the United States, 2001. Am J Prev Med 2004;27:355-62.
34. Ko CW, Kelley K, Meyer KE. Physician specialty and the outcomes and cost of admissions for end-stage liver disease. Am J Gastroenterol 2001;96:3411-8.
35. Talwalkar JA. Determining the extent of quality health care for hospitalized patients with cirrhosis. Hepatology 2005;42:492-4.
36. Nathens AB, Maier RV, Copass MK, et al. Payer status: The unspoken triage criterion. J Trauma 2001;50:776-83.
37. Brasel KJ, Rasmussen J, Cauley C, et al. Reasons for delayed discharge of trauma patients. J Surg Res 2002;107:223-6.
38. Brasel KJ, Lim HJ, Nirula R, et al. Length of stay: An appropriate quality measure? Arch Surg 2007;142:461-5; discussion 465-6.
39. Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroen- terology 2007;132:1261-9.
40. Cowan RE, JacksonBT, Grainger SL, etal. Effects ofanes- thetic agents and abdominal surgery on liver blood flow. Hepatology 1991;14:1161-6.
41. Centers for Disease Control and Prevention. Injury data and resources. Mortality data. Available at: http://www.cdc. gov/nchs/about/otheract/injury/ injury-mortality.htm. Accessed September 15, 2007.
42. Chen LH, Baker SP, Li G. Drinking history and risk of fatal injury: Comparison among specific injury causes. Accid Anal Prev 2005;37:245-51.
43. Elliott MR, Shope JT, Raghunathan TE, et al. Gender differences among young drivers in the association between high- risk driving and substance use/environmental influences. J Stud Alcohol 2006;67:252-60.
44. Das A, Dhiman RK, Saraswat VA, et al. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001;16:531-5.
45. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal- systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977;72:573-83.
46. Poordad FF. Review article: The burden of hepatic en- cephalopathy. Aliment Pharmacol Ther 2007;25(Suppl1):3-9.